The hypothalamo–pituitary–adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome

References

• Adler GK, Kinsley BT, Hurwitz S, Mossey CJ, Goldenberg DL. Reduced hypothalamic–pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med 1999; 106(5)534–543
   PubMed Web of Science ®Google Scholar
• Altemus M, Dale JK, Michelson D, Demitrack MA, Gold PW, Straus SE. Abnormalities in response to vasopressin infusion in chronic fatigue syndrome. Psychoneuroendocrinology 2001; 26(2)175–188
   PubMed Web of Science ®Google Scholar
• Arlt W, Allolio B. Adrenal insufficiency. Lancet 2003; 361(9372)1881–1893
   PubMed Web of Science ®Google Scholar
• Arvat E, Maccagno B, Di Vito L, Gottero C, Talliano M, Ghigo E. ACTH-releasing effect of glucagon in humans. Interaction with hCRH, AVP and hexarelin. J Endocrinol Invest 1999; 22((10 Suppl) 82)24
   PubMedGoogle Scholar
• Blockmans D, Persoons P, Van Houdenhove B, Lejeune M, Bobbaers H. Combination therapy with hydrocortisone and fludrocortisone does not improve symptoms in chronic fatigue syndrome: A randomized, placebo-controlled, double-blind, crossover study. Am J Med 2003; 114(9)736–741
   PubMed Web of Science ®Google Scholar
• Borm K, Slawik M, Seiler L, Flohr F, Petrick M, Honegger J, Reincke M. Is the plasma ACTH concentration a reliable parameter in the insulin tolerance test?. Eur J Endocrinol 2003; 149(6)535–541
   PubMed Web of Science ®Google Scholar
• Borst GC, Michenfelder HJ, O'Brian JT. Discordant cortisol response to exogenous ACTH and insulin-induced hypoglycemia in patients with pituitary disease. N Engl J Med 1982; 306(24)1462–1464
   PubMed Web of Science ®Google Scholar
• Calis M, Gokce C, Ates F, Ulker S, Izgi HB, Demir H, Kirnap M, Sofuoglu S, Durak AC, Tutus A, Kelestimur F. Investigation of the hypothalamo–pituitary–adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome. J Endocrinol Invest 2004; 27(1)42–46
   PubMed Web of Science ®Google Scholar
• Candy B, Chalder T, Cleare AJ, Peakman A, Skowera A, Wessely S, Weinman J, Zuckerman M, Hotopf M. Predictors of fatigue following the onset of infectious mononucleosis. Psychol Med 2003; 33(5)847–855
   PubMed Web of Science ®Google Scholar
• Clark PM, Neylon I, Raggatt PR, Sheppard MC, Stewart PM. Defining the normal cortisol response to the short synacthen test: Implications for the investigation of hypothalamic–pituitary disorders. Clin Endocrinol (Oxf) 1998; 49(3)287–292
   PubMed Web of Science ®Google Scholar
• Clayton RN. Short synacthen test versus insulin stress test for assessment of the hypothalamo [correction of hypothalmo]–pituitary–adrenal axis: Controversy revisited. Clin Endocrinol (Oxf) 1996; 44: 147–149
   PubMed Web of Science ®Google Scholar
• Cleare AJ. The neuroendocrinology of chronic fatigue syndrome. Endocr Rev 2003; 24(2)236–252
   PubMed Web of Science ®Google Scholar
• Cleare AJ. The HPA axis and the genesis of chronic fatigue syndrome. Trends Endocrinol Metab 2004; 15(5)55–59
   PubMedGoogle Scholar
• Cleare AJ, Heap E, Malhi GS, Wessely S, O'Keane V, Miell J. Low-dose hydrocortisone in chronic fatigue syndrome: A randomised crossover trial. Lancet 1999; 353(9151)455–458
   PubMed Web of Science ®Google Scholar
• Cleare AJ, Blair D, Chambers S, Wessely S. Urinary free cortisol in chronic fatigue syndrome. Am J Psychiatry 2001a; 158(4)641–643
   PubMed Web of Science ®Google Scholar
• Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, O'Keane V. Hypothalamo–pituitary–adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. J Clin Endocrinol Metab 2001b; 86(8)3545–3554
   PubMed Web of Science ®Google Scholar
• Cleare AJ, O'Keane V, Miell JP. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome. Psychoneuroendocrinology 2004; 29: 724–732
   PubMed Web of Science ®Google Scholar
• Courtney CH, McAllister AS, McCance DR, Hadden DR, Leslie H, Sheridan B, Atkinson AB. The insulin hypoglycaemia and overnight metyrapone tests in the assessment of the hypothalamic–pituitary–adrenal axis following pituitary surgery. Clin Endocrinol (Oxf) 2000; 53: 309–312
   PubMed Web of Science ®Google Scholar
• Demitrack MA, Dale JK, Straus SE, Laue L, Listwak SJ, Kruesi MJ, Chrousos GP, Gold PW. Evidence for impaired activation of the hypothalamic–pituitary–adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991; 73(6)1224–1234
   PubMed Web of Science ®Google Scholar
• Dickstein G. The assessment of the hypothalamo–pituitary–adrenal axis in pituitary disease: Are there short cuts?. J Endocrinol Invest 2003; 26(7 Suppl)25–30
   PubMedGoogle Scholar
• Dokmetas HS, Colak R, Kelestimur F, Selcuklu A, Unluhizarci K, Bayram F. A comparison between the 1-microg adrenocorticotropin (ACTH) test, the short ACTH (250 microg) test, and the insulin tolerance test in the assessment of hypothalamo–pituitary–adrenal axis immediately after pituitary surgery. J Clin Endocrinol Metab 2000; 85(10)3713–3719
   PubMed Web of Science ®Google Scholar
• Evans JM, Hunder GG. Polymyalgia rheumatica and giant cell arteritis. Rheum Dis Clin North Am 2000; 26(3)493–515
   PubMed Web of Science ®Google Scholar
• Fiad TM, Kirby JM, Cunningham SK, McKenna TJ. The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic–pituitary–adrenal axis. Clin Endocrinol (Oxf) 1994; 40(5)603–609
   PubMed Web of Science ®Google Scholar
• Fries E, Hesse J, Hellhammer J, Hellhammer DH. A new view on hypocortisolism. Psychoneuroendocrinology 2005; 30(10)1010–1016
   PubMed Web of Science ®Google Scholar
• Fukuda K, Strauss SE, Hickie H. The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann Intern Med 1994; 121(12)953–959
   PubMed Web of Science ®Google Scholar
• Gaab J, Huster D, Peisen R, Engert V, Heitz V, Schad T, Schurmeyer TH, Ehlert U. Hypothalamic–pituitary–adrenal axis reactivity in chronic fatigue syndrome and health under psychological, physiological, and pharmacological stimulation. Psychosom Med 2002; 64(6)951–962
   PubMed Web of Science ®Google Scholar
• Gaab J, Huster D, Peisen R, Engert V, Heitz V, Schad T, Schurmeyer T, Ehlert U. Assessment of cortisol response with low-dose and high-dose ACTH in patients with chronic fatigue syndrome and healthy comparison subjects. Psychosomatics 2003; 44(2)113–119
   PubMed Web of Science ®Google Scholar
• Gaab J, Engert V, Heitz V, Schad T, Schurmeyer TH, Ehlert U. Associations between neuroendocrine responses to the insulin tolerance test and patient characteristics in chronic fatigue syndrome. J Psychosom Res 2004; 56(4)419–424
   PubMed Web of Science ®Google Scholar
• Gaab J, Sonderegger L, Scherrer S, Ehlert U. Psychoneuroendocrine effects of cognitive-behavioral stress management in a naturalistic setting—a randomized controlled trial. Psychoneuroendocrinology 2006; 31(4)428–438
   PubMed Web of Science ®Google Scholar
• Geenen R, Jacobs JW, Bijlsma JW. Evaluation and management of endocrine dysfunction in fibromyalgia. Rheum Dis Clin North Am 2002; 28(2)389–404
   PubMed Web of Science ®Google Scholar
• Ghigo E, Bartolotta E, Imperiale E, Bellone J, Cardinale G, Aimaretti G, Valetto MR, Cherubini V, Maccario M, Cocchi D. Glucagon stimulates GH secretion after intramuscular but not intravenous administration. Evidence against the assumption that glucagon per se has a GH-releasing activity. J Endocrinol Invest 1994; 17(11)849–854
   PubMed Web of Science ®Google Scholar
• Goodwin PM, Capildeo R, Harrop JS, Marks V, Rose FC. The metabolic and hormonal response to glucagon. Part 1. Normal subjects. J Neurol Sci 1976; 27(3)373–380
   PubMed Web of Science ®Google Scholar
• Griep EN, Boersma JW, de Kloet ER. Altered reactivity of the hypothalamic–pituitary–adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 1993; 20: 469–474
   PubMed Web of Science ®Google Scholar
• Griep EN, Boersma JW, Lentjes EG, Prins AP, van der Korst JK, de Kloet ER. Function of the hypothalamic–pituitary–adrenal axis in patients with fibromyalgia and low back pain. J Rheumatol 1998; 25(7)1374–1381
   PubMed Web of Science ®Google Scholar
• Grinspoon SK, Biller BM. Clinical review 62: Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 1994; 79(4)923–931
   PubMed Web of Science ®Google Scholar
• Gulmez I, Kelestimur F, Durak AC, Ozesmi M. Changes in the size of adrenal glands in acute pulmonary tuberculosis with therapy. Endocr J 1996; 43(5)573–576
   PubMed Web of Science ®Google Scholar
• Gür A, Cevik R, Nas K, Coplan L, Sarac S. Cortisol and hypothalamic–pituitary–gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on these hormones. Arthritis Res Ther 2004; 6(3)232–238
   Web of Science ®Google Scholar
• Gursel Y, Ergin S, Ulus Y, Erdogan MF, Yalcin P, Evcik D. Hormonal responses to exercise stress test in patients with fibromyalgia syndrome. Clin Rheumatol 2001; 20(6)401–405
   PubMed Web of Science ®Google Scholar
• Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000; 25(1)1–35
   PubMed Web of Science ®Google Scholar
• Hellhammer DH, Wade S. Endocrine correlates of stress vulnerability. Psychother Psychosom 1993; 60(1)8–17
   PubMed Web of Science ®Google Scholar
• Houshyar H, Galigniana MD, Pratt WB, Woods JH. Differential responsivity of the hypothalamic–pituitary–adrenal axis to glucocorticoid negative-feedback and corticotropin releasing hormone in rats undergoing morphine withdrawal: Possible mechanisms involved in facilitated and attenuated stress responses. J Neuroendocrinol 2001; 13(10)875–886
   PubMed Web of Science ®Google Scholar
• Hudson M, Cleare AJ. The 1 microg short synacthen test in chronic fatigue syndrome. Clin Endocrinol (Oxf) 1999; 51(5)625–630
   PubMed Web of Science ®Google Scholar
• Izgi HB, Gökce C, Calis M, Turan T, Kirnap M, Sofuoglu S, Durak AC, Tutus A, Kelestimur F. Investigation of the hypothalamo–pituitary adrenal axis by low dose (1μg) adrenocorticotrophic hormone tests and metyrapone tests in patients with chronic fatigue syndrome. Endocrinologist 2005; 15: 89–92
   Google Scholar
• Jerjes WK, Peters TJ, Taylor NF, Wood PJ, Wessely S, Cleare AJ. Diurnal excretion of urinary cortisol, cortisone, and cortisol metabolites in chronic fatigue syndrome. J Psychosom Res 2006; 60(2)145–153
   PubMed Web of Science ®Google Scholar
• Kavelaars A, Kuis W, Knook L, Sinnema G, Heijnen CJ. Disturbed neuroendocrine–immune interactions in chronic fatigue syndrome. J Clin Endocrinol Metab 2000; 85(2)692–696
   PubMed Web of Science ®Google Scholar
• Kelestimur F, Unlu Y, Ozesmi M, Tolu I. A hormonal and radiological evaluation of adrenal gland in patients with acute or chronic pulmonary tuberculosis. Clin Endocrinol (Oxf) 1994; 41(1)53–56
   PubMed Web of Science ®Google Scholar
• Kelestimur F, Akgun A, Gunay O. A comparison between short synacthen test and depot synacthen test in the evaluation of cortisol reserve of adrenal gland in normal subjects. J Endocrinol Invest 1995; 18(11)823–826
   PubMed Web of Science ®Google Scholar
• Kirnap M, Colak R, Eser C, Ozsoy O, Tutus A, Kelestimur F. A comparison between low-dose (1 microg), standard-dose (250 microg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo–pituitary–adrenal axis in primary fibromyalgia syndrome. Clin Endocrinol (Oxf) 2001; 55(4)455–459
   PubMed Web of Science ®Google Scholar
• Kirschbaum C, Pirke KM, Hellhammer DH. The ‘Trier Social Stress Test’—a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993; 28: 76–81
   PubMed Web of Science ®Google Scholar
• Landon J, James VH, Wharton MJ, Friedman M. Threshold adrenocortical sensitivity in man and its possible application to corticotrophin bioassay. Lancet 1967; 2(7518)697–700
   PubMed Web of Science ®Google Scholar
• Lebrethon MC, Naville D, Begeot M, Saez JM. Regulation of corticotropin receptor number and messenger RNA in cultured human adrenocortical cells by corticotropin and angiotensin II. J Clin Invest 1994; 93(4)1828–1833
   PubMed Web of Science ®Google Scholar
• Leong KS, Walker AB, Martin I, Wile D, Wilding J, MacFarlane IA. An audit of 500 subcutaneous glucagon stimulation tests to assess growth hormone and ACTH secretion in patients with hypothalamic–pituitary disease. Clin Endocrinol (Oxf) 2001; 54(4)463–468
   PubMed Web of Science ®Google Scholar
• McKenzie R, O'Fallon A, Dale J, Demitrack M, Sharma G, Deloria M, Garcia-Borreguero D, Blackwelder W, Straus SE. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: A randomized controlled trial. JAMA 1998; 280(12)1061–1066
   PubMed Web of Science ®Google Scholar
• Melmed S, Kleinberg D. Anterior pituitary. Williams textbook of endocrinology10th ed. Saunders, Philadephia 2003; 177–281
   Google Scholar
• Michelson D, Stone L, Galliven E, Magiakou MA, Chrousos GP, Sternberg EM, Gold PW. Multiple sclerosis is associated with alterations in hypothalamic–pituitary–adrenal axis function. J Clin Endocrinol Metab 1994; 79(3)848–853
   PubMed Web of Science ®Google Scholar
• Morris DG, Grossman AB, Nieman LK. Cushing's syndrome. Endocrinology5th ed. Elsevier, Philadelphia 2006; 438
   Google Scholar
• Murphy BE. Urinary free cortisol determinations: What they measure. Endocrinologist 2002; 12: 143–150
   Google Scholar
• Naitoh Y, Fukata J, Tominaga T, Nakai Y, Tamai S, Mori K, Imura H. Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats. Biochem Biophys Res Commun 1988; 155(3)1459–1463
   PubMed Web of Science ®Google Scholar
• Orth DN, Kovacs WJ. Metyrapone test: The pituitary response to hypocortisolemia. Williams Textbook of Endocrinology, Saunders, Philadelphia 1998; 620–621
   Google Scholar
• Ottenweller JE, Sisto SA, McCarty RC, Natelson BH. Hormonal responses to exercise in chronic fatigue syndrome. Neuropsychobiology 2001; 43(1)34–41
   PubMed Web of Science ®Google Scholar
• Putignano P, Dubini A, Toja P, Invitti C, Bonfanti S, Redaelli G, Zappulli D, Cavagnini F. Salivary cortisol measurement in normal-weight, obese and anorexic women: Comparison with plasma cortisol. Eur J Endocrinol 2001; 145: 165–171
   PubMed Web of Science ®Google Scholar
• Raison CL, Miller AH. When not enough is too much: The role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 2003; 160: 1554–1565
   PubMed Web of Science ®Google Scholar
• Rasmuson S, Olsson T, Hagg E. A low dose ACTH test to assess the function of the hypothalamic–pituitary–adrenal axis. Clin Endocrinol (Oxf) 1996; 44(2)151–156
   PubMed Web of Science ®Google Scholar
• Riedel W, Layka H, Neeck G. Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones. Z Rheumatol 1998; 57(Suppl 2)81–87
   PubMedGoogle Scholar
• Riedel W, Schlapp U, Leck S, Netter P, Neeck G. Blunted ACTH and cortisol responses to systemic injection of corticotropin-releasing hormone (CRH) in fibromyalgia: Role of somatostatin and CRH-binding protein. Ann NY Acad Sci 2002; 966: 483–490
   PubMed Web of Science ®Google Scholar
• Rubin GJ, Hotopf M, Papadopoulos A, Cleare A. Salivary cortisol as a predictor of postoperative fatigue. Psychosom Med 2005; 67(3)441–447
   PubMed Web of Science ®Google Scholar
• Salata RA, Jarrett DB, Verbalis JG, Robinson AG. Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH. J Clin Invest 1988; 81(3)766–774
   PubMed Web of Science ®Google Scholar
• Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 1987; 238(4826)522–524
   PubMed Web of Science ®Google Scholar
• Scott LV, Medbak S, Dinan TG. Blunted adrenocorticotropin and cortisol responses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome. Acta Psychiatr Scand 1998a; 97(6)450–457
   PubMed Web of Science ®Google Scholar
• Scott LV, Medbak S, Dinan TG. The low dose ACTH test in chronic fatigue syndrome and in health. Clin Endocrinol (Oxf) 1998b; 48(6)733–737
   PubMed Web of Science ®Google Scholar
• Scott LV, Medbak S, Dinan TG. Desmopressin augments pituitary-adrenal responsivity to corticotropin-releasing hormone in subjects with chronic fatigue syndrome and in healthy volunteers. Biol Psychiatry 1999a; 45(11)1447–1454
   PubMed Web of Science ®Google Scholar
• Scott LV, Teh J, Reznek R, Martin A, Sohaib A, Dinan TG. Small adrenal glands in chronic fatigue syndrome: A preliminary computer tomography study. Psychoneuroendocrinology 1999b; 24(7)759–768
   PubMed Web of Science ®Google Scholar
• Scott LV, Svec F, Dinan T. A preliminary study of dehydroepiandrosterone response to low-dose ACTH in chronic fatigue syndrome and in healthy subjects. Psychiatry Res 2000; 97(1)21–28
   PubMed Web of Science ®Google Scholar
• Shankar RR, Jakacki RI, Haider A, Lee MW, Pescovitz OH. Testing the hypothalamic–pituitary–adrenal axis in survivors of childhood brain and skull-based tumors. J Clin Endocrinol Metab 1997; 82(6)1995–1998
   PubMed Web of Science ®Google Scholar
• Stewart PM. The adrenal cortex. Williams textbook of endocrinology10th ed. Saunders, Philadelphia 2003; 491–551
   Google Scholar
• Stewart PM, Corrie J, Seckl JR, Edwards CR, Padfield PL. A rational approach for assessing the hypothalamo–pituitary–adrenal axis. Lancet 1988; 1(8596)1208–1210
   PubMed Web of Science ®Google Scholar
• Tordjman K, Jaffe A, Grazas N, Apter C, Stern N. The role of the low dose (1 microgram) adrenocorticotropin test in the evaluation of patients with pituitary diseases. J Clin Endocrinol Metab 1995; 80(4)1301–1305
   PubMed Web of Science ®Google Scholar
• Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, Chrousos GP, Pillemer SR. Responses of the sympathetic nervous system and the hypothalamic–pituitary–adrenal axis to interleukin-6: A pilot study in fibromyalgia. Arthritis Rheum 2000; 43(4)872–880
   PubMedGoogle Scholar
• van Denderen JC, Boersma JW, Zeinstra P, Hollander AP, van Neerbos BR. Physiological effects of exhaustive physical exercise in primary fibromyalgia syndrome (PFS): Is PFS a disorder of neuroendocrine reactivity?. Scand J Rheumatol 1992; 21(1)35–37
   PubMed Web of Science ®Google Scholar
• Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990; 33(2)160–172, Report of the Multicenter Criteria Committee
   PubMed Web of Science ®Google Scholar
• Yildiz O, Gokce C, Alp E, Durak AC, Aygen B, Kelestimur F, Doganay M. Investigation of the hypothalamo–pituitary–adrenal axis and changes in the size of adrenal glands in acute brucellosis. Endocr J 2005; 52(2)183–188
   PubMed Web of Science ®Google Scholar